Biostem U.S. Corp (1455380) SEC Filing 10-Q Quarterly report for the period ending Friday, August 31, 2012

Biostem U.S. Corp

CIK: 1455380
Document and Entity Information
6 Months Ended
Aug. 31, 2012
Oct. 19, 2012
Document And Entity Information    
Entity Registrant Name BIOSTEM U.S. CORPORATION  
Entity Central Index Key 0001455380  
Document Type 10-Q  
Document Period End Date Aug. 31, 2012  
Amendment Flag false  
Current Fiscal Year End Date --02-29  
Is Entity a Well-known Seasoned Issuer? No  
Is Entity a Voluntary Filer? No  
Is Entity's Reporting Status Current? Yes  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   273,365,856
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2012  

View differences made from one quarter to another to evaluate Biostem U.S. Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Biostem U.S. Corp.


Assess how Biostem U.S. Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Biostem U.S. Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2012 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 1455380
Form Type: 10-Q Quarterly Report
Accession Number: 0001477932-12-003932
Submitted to the SEC: Fri Oct 19 2012 2:45:02 PM EST
Accepted by the SEC: Fri Oct 19 2012
Period: Friday, August 31, 2012
Industry: Personal Services

External Resources:

Bookmark the Permalink: